This filing is purely administrative and carries no new information about the company's operations or insider trading. Monitor upcoming Form 4 filings for any open-market purchases or sales by the CFO.
Price Chart
Executive Summary
This is an administrative amendment (Form 3/A) filed by Steven Chan, CFO of Attovia Therapeutics, correcting the reporting person's CIK on the original Form 3 filed August 4, 2026. No changes were made to beneficial ownership — the filing merely re-files the initial statement under the correct individual CIK. The underlying ownership (stock options for 215,285 and 80,731 shares) remains unchanged.
Key Facts
- Form 3/A filed to correct the reporting person's CIK on the original Form 3 filed August 4, 2026
- No changes to beneficial ownership of securities
- Steven Chan is Chief Financial Officer of Attovia Therapeutics
- Chan holds stock options to buy 215,285 shares at $3.5302 (expiring 2034-11-13) and 80,731 shares at $4.9237 (expiring 2035-05-17)
- Options vest over four years with standard 25% cliff and monthly installments
Financial Impact
No financial impact — purely administrative correction of filing metadata
Risk Factors
- None from this filing — no material risk identified
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3/A Filing (Primary) | 0001654907-26-000008 |
| Document: 0001654907-26-000008-index-headers.html | 0001654907-26-000008 |
| Document: 0001654907-26-000008-index.html | 0001654907-26-000008 |
| Document: 0001654907-26-000008.txt | 0001654907-26-000008 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 18d ago | 3/A | $16.21 | awaiting T+20 | — | $14.07 (−13.17%) |
Oct 8, 2026 18d ago | 3/A | $16.21 | awaiting T+20 | — | $14.07 (−13.17%) |
Sep 28, 2026 28d ago | Press Release | $18.16 | awaiting T+20 | — | $14.07 (−22.49%) |
Sep 2, 2026 7w ago | Press Release | $24.20 $17.14 | ▼ −29.17% | ▼ −28.06% | $14.07 (−41.84%) |
Aug 28, 2026 8w ago | 144 / CLUSTER | $21.40 $18.16 | ▼ −15.14% | ▼ −14.95% | $14.07 (−34.23%) |
Aug 13, 2026 10w ago | Insider Buy | $19.86 $24.52 | ▲ +23.46% | ▲ +25.46% | $14.07 (−29.13%) |
Aug 13, 2026 10w ago | Insider Cluster | $19.86 $24.52 | ▲ +23.46% | ▲ +25.46% | $14.07 (−29.13%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.65 $22.86 | ▲ +22.57% | ▲ +23.63% | $14.07 (−24.53%) |
Aug 7, 2026 11w ago | Insider Cluster | $19.84 $23.66 | ▲ +19.25% | ▲ +20.17% | $14.07 (−29.06%) |
Aug 7, 2026 11w ago | Insider Cluster | $20.17 $25.55 | ▲ +26.67% | ▲ +27.07% | $14.07 (−30.22%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers